Acceder

Publicaciones - Obesidad, Diabetes y Metabolismo

Cargando...
Tapias EA, Miles DM, Albillos A, Aller R, Ampuero J, Andrade R, Arechederra M, Aspichueta P, Banales JM, Garcia AB, Caparros E, Delgado TC, Vico AC, Claria J, Cubero FJ, Ruiz AD, Fernandez-Barrena MG, Iglesias AF, Veledo SF, Frances R, Duran RG, Sancho JG, Irimia M, Lens S, Martinez-Chantar ML, Minguez B, Hernandez RM, Nogueiras R, Molina BR, Barciela MR, Rodriguez-Peralvarez ML, Gomez MR, Sabio G, Bru PS, Cots MV, Vidal S, Gahete MD. aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterol Hepatol. 2024 May 7:502207. doi: 10.1016/j.gastrohep.2024.502207. Online ahead of print. English, Spanish. PubMed PMID: 38723772.
AÑO: 2024; IF: 1.9
Lee SM, Muratalla J, Karimi S, Diaz-Ruiz A, Frutos MD, Guzman G, Ramos-Molina B, Cordoba-Chacon J. Hepatocyte PPARgamma contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci. 2023 Jan 11;80(2):39. doi: 10.1007/s00018-022-04629-z. PubMed PMID: 36629912.
AÑO: 2023; IF: 8.0
Luque LM, Carlevaro CM, Llamoza Torres CJ, Lomba E. Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence. PLoS Comput Biol. 2023 Mar 6;19(3):e1010920. doi: 10.1371/journal.pcbi.1010920. Online ahead of print. PubMed PMID: 36877741.
AÑO: 2023; IF: 4.3
Re OL, Lopez-Lopez V, Balaguer-Roman A, Martinez-Sanchez MA, Eshmuminov D, Llamoza-Torres CJ, Miura K, Baroja-Mazo A, Ramirez P, Robles-Campos R, Ramos-Molina B. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8. PubMed PMID: 37000331.
AÑO: 2023; IF: 2.3
Zheng K, Hao F, Medrano-Garcia S, Chen C, Guo F, Moran-Blanco L, Rodriguez-Perales S, Torres-Ruiz R, Peligros MI, Vaquero J, Banares R, Gomez Del Moral M, Regueiro JR, Martinez-Naves E, Mohamed MR, Gallego-Duran R, Maya D, Ampuero J, Romero-Gomez M, Gilbert-Ramos A, Guixe-Muntet S, Fernandez-Iglesias A, Gracia-Sancho J, Coll M, Graupera I, Gines P, Ciudin A, Rivera-Esteban J, Pericas JM, Frutos MD, Ramos Molina B, Herranz JM, Avila MA, Nevzorova YA, Fernandez-Malave E, Cubero FJ. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis. Cell Death Dis. 2023 Aug 10;14(8):514. doi: 10.1038/s41419-023-06029-y. PubMed PMID: 37563155.
AÑO: 2023; IF: 9.0
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII